BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 43 filers reported holding BRIDGEBIO PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,622,500 | -28.4% | 5,850,000 | -41.5% | 1.02% | -3.3% |
| Q2 2023 | $7,848,611 | +5.0% | 10,000,000 | 0.0% | 1.06% | +6.0% |
| Q1 2023 | $7,473,611 | +61.6% | 10,000,000 | 0.0% | 1.00% | +51.3% |
| Q4 2022 | $4,623,611 | -22.6% | 10,000,000 | 0.0% | 0.66% | -8.2% |
| Q3 2022 | $5,974,000 | -28.7% | 10,000,000 | -33.3% | 0.72% | +25.4% |
| Q2 2022 | $8,380,000 | -6.3% | 15,000,000 | 0.0% | 0.57% | +41.4% |
| Q1 2022 | $8,942,000 | -18.0% | 15,000,000 | 0.0% | 0.41% | -38.3% |
| Q4 2021 | $10,910,000 | -47.4% | 15,000,000 | 0.0% | 0.66% | -48.3% |
| Q3 2021 | $20,754,000 | -16.2% | 15,000,000 | 0.0% | 1.27% | -5.8% |
| Q2 2021 | $24,767,000 | – | 15,000,000 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |